Prokidney (PROK) Change in Accured Expenses (2021 - 2026)

Prokidney (PROK) has reported Change in Accured Expenses for 6 consecutive years, with -$2.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Accured Expenses fell 21.76% year-over-year to -$2.7 million in Q2 2026; TTM through Jun 2026 was -$6.5 million, a 169.41% decrease from a year earlier, with the FY2025 full-year figure at -$5.9 million, down 151.06% from the prior year.
• Change in Accured Expenses was -$2.7 million for Q2 2026 at Prokidney, up from -$6.0 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $13.0 million in Q2 2023 and troughed at -$6.0 million in Q1 2026.
• A 5-year average of $507833.3 and a median of $77500.0 in 2024 frame the typical range for Change in Accured Expenses.
• The widest YoY moves for Change in Accured Expenses: up 3452172.73% in 2022, down 2317145.45% in 2022.
• Over 5 years, Change in Accured Expenses stood at $533000.0 in 2022, then surged by 625.14% to $3.9 million in 2023, then soared by 202.87% to $11.7 million in 2024, then tumbled by 81.58% to $2.2 million in 2025, then tumbled by 225.6% to -$2.7 million in 2026.
• The last three Change in Accured Expenses figures came in at -$2.7 million (Q2 2026), -$6.0 million (Q1 2026), and $2.2 million (Q4 2025), per Business Quant data.